Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Caroline Tosch"'
Autor:
Rodrigo Nalio Ramos, Caroline Tosch, Fiorella Kotsias, Marie‐Christine Claudepierre, Doris Schmitt, Christelle Remy‐Ziller, Chantal Hoffmann, Marine Ricordel, Virginie Nourtier, Isabelle Farine, Laurence Laruelle, Julie Hortelano, Clementine Spring‐Giusti, Christine Sedlik, Christophe Le Tourneau, Caroline Hoffmann, Nathalie Silvestre, Philippe Erbs, Kaidre Bendjama, Christine Thioudellet, Eric Quemeneur, Eliane Piaggio, Karola Rittner
Publikováno v:
Clinical & Translational Immunology, Vol 11, Iss 5, Pp n/a-n/a (2022)
Abstract Objective Antitumor viral vaccines, and more particularly poxviral vaccines, represent an active field for clinical development and translational research. To improve the efficacy and treatment outcome, new viral vectors are sought, with emp
Externí odkaz:
https://doaj.org/article/ac5c3ff16464466280384acdc060995a
Autor:
Marine Ricordel, Johann Foloppe, Christelle Pichon, Nathalie Sfrontato, Delphine Antoine, Caroline Tosch, Sandrine Cochin, Pascale Cordier, Eric Quemeneur, Christelle Camus-Bouclainville, Stéphane Bertagnoli, Philippe Erbs
Publikováno v:
Molecular Therapy: Oncolytics, Vol 7, Iss , Pp 1-11 (2017)
Oncolytic virus therapy has recently been recognized as a promising new therapeutic approach for cancer treatment. In this study, we are proposing for the first time to evaluate the in vitro and in vivo oncolytic capacities of the Cowpox virus (CPXV)
Externí odkaz:
https://doaj.org/article/44392a60173940d8892418f9893e13c1
Autor:
Caroline Tosch, Bérangère Bastien, Luc Barraud, Benoit Grellier, Virginie Nourtier, Murielle Gantzer, Jean Marc Limacher, Eric Quemeneur, Kaïdre Bendjama, Xavier Préville
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 5, Iss 1, Pp 1-10 (2017)
Abstract Background Advanced non-small cell lung cancer patients receiving TG4010, a therapeutic viral vaccine encoding human Mucin 1 and interleukin-2 in addition to standard chemotherapy, displayed longer overall survival in comparison to that of p
Externí odkaz:
https://doaj.org/article/76dc2c8570884a3c903109baf301346e
Publikováno v:
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-11 (2017)
Abstract Background The success of immunotherapeutics in oncology and the search for further improvements has prompted revisiting the use of cancer vaccines. In this context, knowledge of the immunogenic epitopes and the monitoring of the immune resp
Externí odkaz:
https://doaj.org/article/aa16a3c1b96347e4954e13c6067935dc
Autor:
Lucas Walther, Caroline Tosch, Jules Deforges, Christine Carapito, Magali Rompais, Marie-Christine Claudepierre, Nathalie Silvestre, Kaïdre Bendjama, Eric Quemeneur, Jacky Goetz, Vincent Hyenne, Karola Rittner
Publikováno v:
Cancer Research. 83:697-697
Virus-based therapies show promise in inducing systemic anti-tumor immunity. Over the past years, modified poxviruses were developed to induce a sustained antitumoral immune response. Several studies confirm this hypothesis and report induction of T
Autor:
Rodrigo Nalio Ramos, Caroline Tosch, Fiorella Kotsias, Marie‐Christine Claudepierre, Doris Schmitt, Christelle Remy‐Ziller, Chantal Hoffmann, Marine Ricordel, Virginie Nourtier, Isabelle Farine, Laurence Laruelle, Julie Hortelano, Clementine Spring‐Giusti, Christine Sedlik, Christophe Le Tourneau, Caroline Hoffmann, Nathalie Silvestre, Philippe Erbs, Kaidre Bendjama, Christine Thioudellet, Eric Quemeneur, Eliane Piaggio, Karola Rittner
Publikováno v:
Clinicaltranslational immunology. 11(5)
Antitumor viral vaccines, and more particularly poxviral vaccines, represent an active field for clinical development and translational research. To improve the efficacy and treatment outcome, new viral vectors are sought, with emphasis on their abil
Autor:
Kousuke Onoue, Eric Quemeneur, Kaïdre Bendjama, Karola Rittner, Benoît Grellier, Caroline Tosch, Timo Sztyler, Brandon Malone, Yoshiko Yamashita
Publikováno v:
Cancer Research. 80:4566-4566
The development of therapeutic cancer vaccines to immunize against tumor antigens constitutes a promising modality. Mutation associated antigens are considered major targets given their specificity to tumor cells. These mutations are specific to the
Autor:
Philippe Erbs, Eric Quemeneur, Marine Ricordel, Stéphane Bertagnoli, Johann Foloppe, Christelle Pichon, Sandrine Cochin, Pascale Cordier, Caroline Tosch, Annie Findeli, Christelle Camus-Bouclainville
Publikováno v:
Oncotarget 89 (9), 35891-35906. (2018)
Oncotarget
Oncotarget, Impact journals, 2018, 9 (89), pp.35891-35906. ⟨10.18632/oncotarget.26288⟩
Oncotarget
Oncotarget, Impact journals, 2018, 9 (89), pp.35891-35906. ⟨10.18632/oncotarget.26288⟩
International audience; Vaccinia virus, a member of the Poxviridae family, has been extensively used as an oncolytic agent and has entered late stage clinical development. In this study, we evaluated the potential oncolytic properties of other member
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e39d3788ad2348f74939c1538fc4ab11
http://prodinra.inra.fr/record/458356
http://prodinra.inra.fr/record/458356
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, 2017, 15 (1), pp.154. ⟨10.1186/s12967-017-1254-0⟩
Journal of Translational Medicine, BioMed Central, 2017, 15 (1), pp.154. ⟨10.1186/s12967-017-1254-0⟩
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-11 (2017)
Journal of Translational Medicine, BioMed Central, 2017, 15 (1), pp.154. 〈10.1186/s12967-017-1254-0〉
Journal of Translational Medicine, 2017, 15 (1), pp.154. ⟨10.1186/s12967-017-1254-0⟩
Journal of Translational Medicine, BioMed Central, 2017, 15 (1), pp.154. ⟨10.1186/s12967-017-1254-0⟩
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-11 (2017)
Journal of Translational Medicine, BioMed Central, 2017, 15 (1), pp.154. 〈10.1186/s12967-017-1254-0〉
Background The success of immunotherapeutics in oncology and the search for further improvements has prompted revisiting the use of cancer vaccines. In this context, knowledge of the immunogenic epitopes and the monitoring of the immune response canc
Autor:
Stéphane Bertagnoli, Johann Foloppe, Marine Ricordel, Delphine Antoine, Pascale Cordier, Sandrine Cochin, Christelle Camus-Bouclainville, Eric Quemeneur, Nathalie Sfrontato, Philippe Erbs, Christelle Pichon, Caroline Tosch
Publikováno v:
Molecular Therapy-Oncolytics
Molecular Therapy-Oncolytics, Elsevier, 2017, 7, pp.1-11. ⟨10.1016/j.omto.2017.08.003⟩
Molecular Therapy: Oncolytics, Vol 7, Iss, Pp 1-11 (2017)
Molecular Therapy Oncolytics (7), 1-11. (2017)
Molecular Therapy Oncolytics
Molecular Therapy-Oncolytics, Elsevier, 2017, 7, pp.1-11. ⟨10.1016/j.omto.2017.08.003⟩
Molecular Therapy: Oncolytics, Vol 7, Iss, Pp 1-11 (2017)
Molecular Therapy Oncolytics (7), 1-11. (2017)
Molecular Therapy Oncolytics
Oncolytic virus therapy has recently been recognized as a promising new therapeutic approach for cancer treatment. In this study, we are proposing for the first time to evaluate the in vitro and in vivo oncolytic capacities of the Cowpox virus (CPXV)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cc3a0357785b66f3a6cee6494c76f42
https://hal.inrae.fr/hal-02622526/document
https://hal.inrae.fr/hal-02622526/document